https://magnasense-dev.mywoosh.site/https://magnasense-dev.mywoosh.site/news/https://magnasense-dev.mywoosh.site/investor-relations/financial-calendar/https://magnasense-dev.mywoosh.site/investor-relations/share-issues-merger-acquisitions/mergers-acquisitions-2021/https://magnasense-dev.mywoosh.site/investor-relations/share-issues-merger-acquisitions/foretradesemission-2022/https://magnasense-dev.mywoosh.site/investor-relations/ir-news/https://magnasense-dev.mywoosh.site/investor-relations/ir-contact/https://magnasense-dev.mywoosh.site/news/aegirbio-tillkannager-sin-forsta-kliniska-salivtdm/https://magnasense-dev.mywoosh.site/news/aegirbio-announces-first-clinical-saliva-tdm-study/https://magnasense-dev.mywoosh.site/news/korrigering-av-tidigare-publicerad-pressrelease-om/https://magnasense-dev.mywoosh.site/news/nils-paulsson-ny-coo-pa-aegirbio/https://magnasense-dev.mywoosh.site/news/vd-bradley-messmer-kommenterar-kvartalsrapporten/https://magnasense-dev.mywoosh.site/news/aegirbio-publicerar-presentation-och-arrangerar-di/https://magnasense-dev.mywoosh.site/news/aegirbio-och-istoc-inleder-samarbete-om-en-datahan/https://magnasense-dev.mywoosh.site/news/aegirbio-presentation-and-discussion-session-at-ec/https://magnasense-dev.mywoosh.site/news/aegirbio-and-istoc-to-cooperate-with-a-data-manage/https://magnasense-dev.mywoosh.site/news/kommunike-fran-arsstamma-i-aegirbio-ab-publ-den-30/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-offentliggor-utfall-i-foretradesemissi/https://magnasense-dev.mywoosh.site/news/sista-dagen-att-teckna-units-i-aegirbios-pagaende-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-offentliggor-eutillvaxtprospekt-med-an/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publ-publicerar-sin-arsredovisning-for1/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publ-publicerar-sin-arsredovisning-for/https://magnasense-dev.mywoosh.site/news/kallelse-till-arsstamma-i-aegirbio-ab-publ/https://magnasense-dev.mywoosh.site/news/aegirbio-ce-marker-tva-av-sina-tdm-tester-for-poc/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-och-redogor-for-vasen-2022-05/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-genomfor-foretradesemission-av-units-o/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-utser-patrik-gotthardt-till-interim-cf/https://magnasense-dev.mywoosh.site/news/viraspec-godkanns-och-cemarks-for-sjalvtest/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-lamnar-in-patentansokan/https://magnasense-dev.mywoosh.site/news/bradley-messmer-tilltrader-som-vd-for-aegirbio/https://magnasense-dev.mywoosh.site/news/intervju-med-aegirbios-tilltradande-vd-dr-bradley-/https://magnasense-dev.mywoosh.site/news/abreos-ett-dotterbolag-till-aegirbio-lamnar-in-pat/https://magnasense-dev.mywoosh.site/news/aegirbios-cfo-avgar/https://magnasense-dev.mywoosh.site/news/bokslutskommunike-2021/https://magnasense-dev.mywoosh.site/news/bolaget-bedomer-idag-att-avtalet-avseende-forsaljn/https://magnasense-dev.mywoosh.site/news/bradley-messmer-tilltrader-som-vd-for-aegirbio-for/https://magnasense-dev.mywoosh.site/news/uppdatering-om-organisation-i-aegirbio/https://magnasense-dev.mywoosh.site/news/statusuppdatering-avseende-forsaljningslage-och-ti/https://magnasense-dev.mywoosh.site/news/avseende-utbyte-av-aktier-i-lifeassays-ab-mot-akti/https://magnasense-dev.mywoosh.site/news/aegirbio-har-tecknat-logistikavtal-med-schenker-lo/https://magnasense-dev.mywoosh.site/news/fordrojt-godkannande-av-aegirbios-sjalvtest-for-co/https://magnasense-dev.mywoosh.site/news/aegirbio-erhaller-godkannande-av-patent-fran-europ/https://magnasense-dev.mywoosh.site/news/pcr-och-antigentests-anvandbarhet-pa-omikronvarian/https://magnasense-dev.mywoosh.site/news/kommentarer-avseende-uppgifter-i-media-samt-status/https://magnasense-dev.mywoosh.site/news/forsening-avseende-cemarkning-av-bolagets-covid19-/https://magnasense-dev.mywoosh.site/news/rattelse-saknad-maretikett-i-tidigare-pressmeddela/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-for-perioden-januari-/https://magnasense-dev.mywoosh.site/news/forandring-av-leveransvolymer-och-leveranstidpunkt/https://magnasense-dev.mywoosh.site/news/meddelande-till-aegirbios-aktieagare/https://magnasense-dev.mywoosh.site/news/aegirbio-terminates-distribution-agreement-with-no/https://magnasense-dev.mywoosh.site/news/aegirbio-avslutar-distributionsavtal-med-nowmed-sw/https://magnasense-dev.mywoosh.site/news/patrik-elfwing-blir-tillforordnad-vd-for-aegirbio/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-och-dynamic-code-valjer-att-inte-forts/https://magnasense-dev.mywoosh.site/news/angaende-svts-inslag-om-aegirbio-och-misstankta-i-momsbedrageriharva/https://magnasense-dev.mywoosh.site/news/aegirbio-tecknar-nytt-avtal-for-indien-om-minst-20-miljoner-tester-och-lamnar-samtidigt-har-en-statusuppdatering/https://magnasense-dev.mywoosh.site/news/aegirbio-lanserar-test-som-pavisar-om-man-som-individ-har-antikroppar-mot-covid19-efter-vaccination/https://magnasense-dev.mywoosh.site/news/biostock-studio-aegirbios-vd-om-forvarvet-av-dynamic-code/https://magnasense-dev.mywoosh.site/news/fortydligande-avseende-aegirbios-aktiepris-och-pre/https://magnasense-dev.mywoosh.site/news/aegirbio-acquires-dynamic-code-starts-strategic-construction-of-international-healthtech-operator/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-has-carried-out-a-directed-issue-of-shares-of-msek-1274-and-obtained-debt-financing-of-msek-75/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-signs-share-transfer-agreement-with-regard-to-the-acquisition-of-dynamic-code-ab-/https://magnasense-dev.mywoosh.site/news/aegirbio-forvarvar-dynamic-code-startar-strategisk/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-har-genomfort-en-riktad-nyemission-om-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-tecknar-aktieoverlatelseavtal-avseende/https://magnasense-dev.mywoosh.site/news/aegirbios-salivtest-godkand-av-thailands-fda-som-hemtest-och-bolagets-forsta-stora-leverans-genomford/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-avger-halvarsrapport/https://magnasense-dev.mywoosh.site/news/aegirbio-bygger-organisation-for-framtiden/https://magnasense-dev.mywoosh.site/news/avgorande-steg-i-utvecklingen-av-aegirbios-snabbte/https://magnasense-dev.mywoosh.site/news/aegirbios-salivtest-godkand-av-thailands-fda/https://magnasense-dev.mywoosh.site/news/aegirbios-saliva-test-approved-by-thailands-fda/https://magnasense-dev.mywoosh.site/news/aegirbio-receives-new-major-order-from-asia-worth-in-excess-of-msek-400-vietnam-becomes-the-next-country-of-establishment/https://magnasense-dev.mywoosh.site/news/aegirbio-far-ny-stororder-pa-drygt-400-miljoner-ti/https://magnasense-dev.mywoosh.site/news/aegirbio-receives-its-first-order-worth-more-than-msek-400/https://magnasense-dev.mywoosh.site/news/aegirbio-far-forsta-order-pa-drygt-400-miljoner-kr/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-ensures-production-capacity/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-sakrar-produktionskapacitet/https://magnasense-dev.mywoosh.site/news/aegirbio-receives-an-intention-to-grant-from-the-e/https://magnasense-dev.mywoosh.site/news/aegirbio-har-fatt-preliminart-godkannande-av-europ/https://magnasense-dev.mywoosh.site/news/kommunike-fran-aegirbios-arsstamma-2021/https://magnasense-dev.mywoosh.site/news/aegirbio-erhaller-testorder-pa-100-miljoner-kronor/https://magnasense-dev.mywoosh.site/news/aegirbio-genomfor-forvarvet-av-abreos-genom-apportemission/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-avslutar-likviditetsgarant/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publicerar-sin-arsredovisning-for-2020/https://magnasense-dev.mywoosh.site/news/kort-uppdatering-om-forsaljningslaget-i-aegirbio-a/https://magnasense-dev.mywoosh.site/news/aegirbio-forbereder-listbyte-till-nasdaq-stockholm/https://magnasense-dev.mywoosh.site/news/bolagsverket-har-idag-registrerat-fusionen-mellan-/https://magnasense-dev.mywoosh.site/news/kallelse-till-arsstamma-i-aegirbio-ab/https://magnasense-dev.mywoosh.site/news/aegirbios-covidtest-godkant-i-tyskland-av-bfarm/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publ-delarsrapport-januari-till-mars-2/https://magnasense-dev.mywoosh.site/news/bolagsverket-har-lamnat-tillstand-att-verkstalla-f/https://magnasense-dev.mywoosh.site/news/aegirbio-utsedd-till-basta-notering-2020-av-affars/https://magnasense-dev.mywoosh.site/news/aegirbio-sakrar-rorelsekapital-for-expansion-och-t/https://magnasense-dev.mywoosh.site/news/clarification-of-aegirbios-new-distribution-agreement/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-signs-distribution-agreement-for-covid19-test-receives-order-for-at-least-msek-40/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-tecknar-avtal-om-forsaljning-av-covid1/https://magnasense-dev.mywoosh.site/news/klargorande-kring-aegirbios-nya-distributionsavtal/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-tecknar-distributionsavtal-for-covid19/https://magnasense-dev.mywoosh.site/news/aegirbio-launches-rapid-test-for-covid19/https://magnasense-dev.mywoosh.site/news/aegirbio-lanserar-snabbtest-for-covid19/https://magnasense-dev.mywoosh.site/news/styrelseledamot-kristian-enkvist-avgar-pa-egen-beg/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-meddelar-att-slutlig-inlosen-av-to1-ha/https://magnasense-dev.mywoosh.site/news/aegirbio-prepares-for-launch-but-postpones-launch-for-up-to-a-few-weeks/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-laddar-for-lansering-men-skjuter-pa-la/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-meddelar-att-sista-dagen-for-inlosen-a/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-meddelar-att-inlosen-av-to1-har-i-febr/https://magnasense-dev.mywoosh.site/news/information-fran-aegirbio-abs-extra-bolagsstamma/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publ-avger-bokslutskommunike-for-raken/https://magnasense-dev.mywoosh.site/news/aegirbio-offentliggor-fusionsdokument/https://magnasense-dev.mywoosh.site/news/aegirbio-offentliggor-preliminar-finansiell-inform/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-employee-brandon-steele-as-its-chief-c/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-anstaller-brandon-steele-i-rollen-som-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-meddelar-att-inlosen-av-to1-har-i-janu/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-kallar-till-extra-bolagsstamma/https://magnasense-dev.mywoosh.site/news/aegirbio-creates-the-multidiagnostic-company-of-the-future-acquires-lifeassays-and-abreos-bioscience/https://magnasense-dev.mywoosh.site/news/aegirbios-vd-martin-linde-i-intervju-om-aegirbios-/https://magnasense-dev.mywoosh.site/news/sammanfattande-pm-aegirbio-skapar-framtidens-multi/https://magnasense-dev.mywoosh.site/news/aegirbio-och-lifeassays-foreslas-fusioneras/https://magnasense-dev.mywoosh.site/news/aegirbio-ingar-avtal-om-att-forvarva-samtliga-akti/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-meddelar-att-inlosen-av-to1-har-i-dece/https://magnasense-dev.mywoosh.site/news/direct-aid-of-approximately-msek-43-or-419500-gran/https://magnasense-dev.mywoosh.site/news/aegirbio-abs-ansokan-hos-eurostar-beviljas-direkt-/https://magnasense-dev.mywoosh.site/news/aegirbios-eurostar-application-concerning-covid19-/https://magnasense-dev.mywoosh.site/news/aegirbios-ansokan-hos-eurostar-for-covid19-detecti/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publ-meddelar-att-inlosen-av-to1-har-i/https://magnasense-dev.mywoosh.site/news/delarsrapport-aegirbio-ab-publ-for-perioden-januar/https://magnasense-dev.mywoosh.site/news/aegirbio-commences-fda-fast-track-process-with-the/https://magnasense-dev.mywoosh.site/news/aegirbio-startar-fdaprocessen-for-snabbgodkannande/https://magnasense-dev.mywoosh.site/news/convincing-results-for-aegirbios-coronavirus-test-/https://magnasense-dev.mywoosh.site/news/aegirbios-covidtest-levererar-overtygande-resultat1/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-aegirbio-eller-bolaget-meddelar-att-in/https://magnasense-dev.mywoosh.site/news/styrelsen-beslutar-om-apportemissioner-av-aktier-i/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-overgar-till-ifrs-redovisningsstandard/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-signs-a-research-development-agreement/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-signerar-ett-forsknings-och-utveckling/https://magnasense-dev.mywoosh.site/news/aegirbio-deltar-vid-financial-meeting-oresunds-kap/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-informerar-om-att-aktietips-bjuder-in-/https://magnasense-dev.mywoosh.site/news/aegirbio-abs-nyforvarvade-dotterbolag-thyrolytics-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-tillfors-cirka-830-000-kr-genom-inlose/https://magnasense-dev.mywoosh.site/news/biostock-studio-aegirbios-vd-om-nyforvarven/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-fortsatter-sin-forvarvsresa-och-forvarvar-diagnostikbolaget-thyrolytics-ab/https://magnasense-dev.mywoosh.site/news/aegirbio-abs-nyforvarv-viraspec-ab-tecknar-avtal-med-kund-for-sluttest-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-strengthens-covid19-effort-acquires-viraspec-ab/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-starker-sin-satsning-pa-covid19-och-forvarvar-viraspec-ab/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publ-meddelar-att-inlosen-av-to1-har-i-augusti-tillfort-bolaget-cirka-67-msek-fore-emissionskostnader/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-okar-takten-pa-forsaljningen/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-okar-takten-pa-produktutvecklingen/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publicerar-halvarsarpport-for-januari-juni-2020/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-interim-report-jan-jun-2020/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-tillfors-cirka-36-msek-genom-inlosen-a/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-sjosatter-ny-strategi-fran-precisionsd/https://magnasense-dev.mywoosh.site/news/handel-med-aktier-i-aegirbio-ab-inleds-idag-pa-nasdaq-first-north-growth-market/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-har-godkants-for-notering-pa-nasdaq-first-north-growth-market/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-s-unitemission-kraftigt-overtecknad/https://magnasense-dev.mywoosh.site/news/aegirbios-vd-martin-linde-intervjuad-av-biostock/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-haller-ikvall-en-foeretagspresentation-pa-smabolagsdagarna-2020/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-offentliggor-tillvaxtprospekt-avseende-emission-av-units-infor-notering-pa-nasdaq-first-north-growth-market/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-presenterar-pa-biostock-live/https://magnasense-dev.mywoosh.site/news/stor-uppmarksamhet-foer-aegirbios-tester-av-covid-19/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-kommer-att-ansoeka-om-notering-pa-nasdaq-first-north-growth-market/https://magnasense-dev.mywoosh.site/news/aegirbios-har-genomfoert-sin-forsta-forsaljning/https://magnasense-dev.mywoosh.site/news/aegirbio-has-completed-its-first-sale/https://magnasense-dev.mywoosh.site/news/new-business-area-aegirbio-s-technology-can-demonstrate-immunity-to-corona-virus/https://magnasense-dev.mywoosh.site/news/aegirbio-lanserar-monitorering-av-ms-pa-actrims-forums-moete-i-florida-usa-den-27-2/https://magnasense-dev.mywoosh.site/news/visit-us-at-actrims-2020-and-learn-more-about-precision-dosing-of-tysabri-(natalizumab)/https://magnasense-dev.mywoosh.site/news/abreos-far-bidrag-pa-850-000-usd-foer-att-monitorera-crohns-sjukdom/https://magnasense-dev.mywoosh.site/news/lifeassays-samarbetspartner-abreos-och-fda-i-samarbete-foer-att-utveckla-metod-foer-att-mata-koncentrationen-av-aktivt-lakemedel-i-blod/https://magnasense-dev.mywoosh.site/news/aegirbio-har-genomfoert-en-pre-ipo-och-tagit-in-4-5-msek/https://magnasense-dev.mywoosh.site/news/the-next-step-is-taken-for-aegirbio-a-pre-ipo-based-on-a-value-of-the-company-of-70-million-completed/https://magnasense-dev.mywoosh.site/news/lifeassays-aegirbio-ab-kommer-ansoeka-om-notering-pa-spotlight-stock-market/https://magnasense-dev.mywoosh.site/news/abreos-biosciences-vd-utsedd-till-usas-mest-influensrika-vd-i-lakemedelsbranschen-2019/https://magnasense-dev.mywoosh.site/news/aegirbio-har-fatt-godkannande-fran-det-anmalda-organet-notified-body-att-forlanga-hallbarheten-for-sitt-covid19antigentest/https://magnasense-dev.mywoosh.site/news/aegirbio-has-received-approval-from-the-notified-body-to-prolong-the-shelf-life-of-its-covid19-antigen-test/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-utser-jonas-persson-till-interim-cfo/https://magnasense-dev.mywoosh.site/news/aegirbios-test-avseende-covid19-forsaljningsstoppas-tillfalligt/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-och-redogor-for-vasentliga-handelser-202211/https://magnasense-dev.mywoosh.site/news/vd-bradley-messmer-kommenterar-kvartalsrapporten/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-ingar-avtal-med-atlas-special-opportun/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-enters-into-an-agreement-with-atlas-sp/https://magnasense-dev.mywoosh.site/news/kallelse-till-extra-bolagsstamma-i-aegirbio-ab-publ/https://magnasense-dev.mywoosh.site/news/aegirbio-har-idag-informerats-om-att-nasdaq-stockh/https://magnasense-dev.mywoosh.site/news/aegirbio-utser-niklas-andersson-till-ny-cfo/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-nyttjandeperioden-for-teckningsoptione/https://magnasense-dev.mywoosh.site/news/kommunike-fran-extra-bolagsstamma-i-aegirbio-ab-publ-den-20-januari-2023/https://magnasense-dev.mywoosh.site/news/aegirbio-senarelagger-bokslutskommuniken-for-2022-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-forlanger-teckningstiden-och-tiden-for/https://magnasense-dev.mywoosh.site/news/aegirbio-uk-facility-iso-13485-compliant/https://magnasense-dev.mywoosh.site/news/forsaljningen-av-viraspec-covid-19-tester-aterupptas/https://magnasense-dev.mywoosh.site/news/sales-of-viraspec-covid-19-tests-are-being-resumed/https://magnasense-dev.mywoosh.site/news/aegirbios-presentation-pa-actrims/https://magnasense-dev.mywoosh.site/news/aegirbio-presentation-at-actrims/https://magnasense-dev.mywoosh.site/news/nasdaq-stockholms-disciplinnamnd-har-beslutat-att-/https://magnasense-dev.mywoosh.site/news/the-disciplinary-committee-of-nasdaq-stockholm-has-resolved-that-aegirbio-shall-pay-fees/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-atlas-special-opportunities-llc-pakall/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-atlas-special-opportunities-llc-calls-for-partial-conversion-of-outstanding-convertible-bonds-to-a-nominal-amount-of-msek-1000/https://magnasense-dev.mywoosh.site/news/bokslutskommunike-2022/https://magnasense-dev.mywoosh.site/news/finansinspektionen-startar-utredning-av-aegirbios-/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-utser-christel-dahlberg-till-interim-cfo/https://magnasense-dev.mywoosh.site/news/aegirbio-rapporterar-icke-kassapaverkande-kostnad-/https://magnasense-dev.mywoosh.site/news/aegirbio-utser-ny-vd/https://magnasense-dev.mywoosh.site/news/aegirbio-appoints-new-ceo/https://magnasense-dev.mywoosh.site/news/kallelse-till-arsstamma-i-aegirbio-ab-publ/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-och-redogor-for-vasentliga-handelser-202305/https://magnasense-dev.mywoosh.site/news/aegirbio-senarelagger-publicering-av-arsredovisnin/https://magnasense-dev.mywoosh.site/news/rattelse-nils-paulsson-lamnar-rollen-som-coo/https://magnasense-dev.mywoosh.site/news/nils-paulsson-lamnar-rollen-som-ceo/https://magnasense-dev.mywoosh.site/news/aegirbio-senarelagger-publiceringen-av-arsredovisningen-for-rakenskapsaret-2022/https://magnasense-dev.mywoosh.site/news/kommunike-fran-arsstamma-i-aegirbio-ab-publ-den-30-2023-06-30/https://magnasense-dev.mywoosh.site/news/aegirbio-sluter-avtal-med-salofa-for-veterinarmark/https://magnasense-dev.mywoosh.site/news/aegirbio-signs-agreement-with-salofa-for-the-veter/https://magnasense-dev.mywoosh.site/news/aegirbio-senarelagger-publiceringen-av-arsredovisningen-for-rakenskapsaret-2022/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-har-fatt-programmatiskt-godkannande-av/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-has-received-national-institutes-of-he/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publicerar-arsredovisning-och-revision/https://magnasense-dev.mywoosh.site/news/rattelse-aegirbio-avger-delarsrapport-och-redogor-/https://magnasense-dev.mywoosh.site/news/kallelse-till-fortsatt-arsstamma-i-aegirbio-ab-pub/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-och-redogor-for-vasentliga-handelser-202308/https://magnasense-dev.mywoosh.site/news/kommunike-fran-fortsatt-arsstamma-i-aegirbio-ab-publ-den-25-augusti-2023/https://magnasense-dev.mywoosh.site/news/aegirbio-publish-video-presentation-by-ceo-marco-witteveen/https://magnasense-dev.mywoosh.site/news/aegirbio-receives-12-million-nih-award/https://magnasense-dev.mywoosh.site/news/aegirbio-promotes-dr-vasiliki-fragkou-to-chief-ope/https://magnasense-dev.mywoosh.site/news/interview-with-aegirbio-ceo-mr-marco-witteveen/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-receives-239-547-award-from-the-nation/https://magnasense-dev.mywoosh.site/news/aegirbio-focuses-on-radx-project-will-not-uphold-c/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-utser-christel-dahlberg-till-cfo/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-och-redogor-for-vasentliga-handelser-202311/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-atlas-special-opportunities-llc-pakall-2023-12-20/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-atlas-special-opportunities-llc-calls-for-partial-conversion-of-outstanding-convertible-bonds-to-a-nominal-amount-of-msek-500/https://magnasense-dev.mywoosh.site/technology/oral-health/https://magnasense-dev.mywoosh.site/technology/overview/https://magnasense-dev.mywoosh.site/technology/therapeutic-drug-monitoring/https://magnasense-dev.mywoosh.site/technology/infectious-diseases/https://magnasense-dev.mywoosh.site/news/renowned-gastroenterologist-dr-adam-s-cheifetz-joi/https://magnasense-dev.mywoosh.site/news/aegirbio-utokar-sitt-scientific-advisory-board-inom-oral-halsa-med-professor-iain-lc-chapple/https://magnasense-dev.mywoosh.site/news/aegirbio-expands-oral-health-scientific-advisory-board-with-professor-iain-lc-chapple/https://magnasense-dev.mywoosh.site/news/finansinspektionen-begar-yttrande-fran-aegirbio-ab/https://magnasense-dev.mywoosh.site/investor-relations/financial-reports/https://magnasense-dev.mywoosh.site/investor-relations/the-share/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/general/https://magnasense-dev.mywoosh.site/investor-relations/bolagsstyrning/allmant/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/articles-of-association/https://magnasense-dev.mywoosh.site/investor-relations/share-issues-merger-acquisitions/ipo-2020/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/general-meetings/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/board-of-directors/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/management-team/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/auditor/https://magnasense-dev.mywoosh.site/investor-relations/corporate-governance/certified-adviser/https://magnasense-dev.mywoosh.site/investor-relations/bolagsstyrning/bolagsordning/https://magnasense-dev.mywoosh.site/investor-relations/bolagsstyrning/bolagsstamma/https://magnasense-dev.mywoosh.site/investor-relations/bolagsstyrning/styrelse/https://magnasense-dev.mywoosh.site/investor-relations/bolagsstyrning/koncernledning/https://magnasense-dev.mywoosh.site/investor-relations/bolagsstyrning/revisor/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-bokslutskommunike-och-redogor-for-v/https://magnasense-dev.mywoosh.site/news/aegirbios-styrelseordforande-har-meddelat-sin-avsi/https://magnasense-dev.mywoosh.site/news/aegirbio-ingar-villkorat-avtal-om-en-lanefacilitet/https://magnasense-dev.mywoosh.site/news/aegirbios-chairman-has-announced-his-intention-to-leave-the-board-of-directors/https://magnasense-dev.mywoosh.site/news/aegirbio-enters-into-a-conditional-agreement-on-a-msek-45-loan-facility-with-atlas-special-opportunities-and-an-agreement-to-amend-the-outstanding-convertible-bonds-subject-to-egm-approval/https://magnasense-dev.mywoosh.site/news/kallelse-till-extra-bolagsstamma-i-aegirbio-ab-publ/https://magnasense-dev.mywoosh.site/news/aegirbio-abs-dotterbolag-pakallar-skiljeforfarande/https://magnasense-dev.mywoosh.site/news/aegirbio-abs-subsidiary-initiates-arbitration-agai/https://magnasense-dev.mywoosh.site/news/kommunike-fran-extra-bolagsstamma-i-aegirbio-ab-pu/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-gor-ytterligare-framsteg-och-slutfor-m/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-advances-further-with-accessibility-mi/https://magnasense-dev.mywoosh.site/news/company-update/https://magnasense-dev.mywoosh.site/news/aegirbio-erhaller-milstolpsbetalning-under-radx-ni/https://magnasense-dev.mywoosh.site/news/aegirbio-receives-milestone-payment-under-radx-nih/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-pakallar-utbetalning-av-tranche-1-om-7/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-calls-for-payment-of-tranche-1-of-sek-/https://magnasense-dev.mywoosh.site/news/aegirbio-studie-publicerad-i-tidskriften-multiple-/https://magnasense-dev.mywoosh.site/news/aegirbio-study-published-in-multiple-sclerosis-and/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-slutfor-framgangsrikt-ytterligare-en-m/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-successfully-completes-an-additional-m/https://magnasense-dev.mywoosh.site/news/kallelse-till-arsstamma-i-aegirbio-ab-publ/https://magnasense-dev.mywoosh.site/news/aegirbios-vd-marco-witteveen-deltar-i-salivadirect/https://magnasense-dev.mywoosh.site/news/aegirbios-ceo-marco-witteveen-to-attend-salivadire/https://magnasense-dev.mywoosh.site/news/subscribe/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-genomfor-tidigare-aviserad-riktad-nyem/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-carries-out-previously-announced-direc/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-publicerar-arsredovisning-och-revisionsberattelse-for-rakenskapsaret-2023/https://magnasense-dev.mywoosh.site/news/aegirbio-announces-strategic-name-change-to-magnoral-ab/https://magnasense-dev.mywoosh.site/news/aegirbio-tillkannager-strategiskt-namnbyte-till-magnoral-ab/https://magnasense-dev.mywoosh.site/news/aegirbio-erhaller-ytterligare-milstolpsbetalning-u/https://magnasense-dev.mywoosh.site/news/aegirbio-receives-second-milestone-payment-under-radx-nih/https://magnasense-dev.mywoosh.site/updates/5-qa-with-magnasense-ceo-marco-witteveen/https://magnasense-dev.mywoosh.site/updates/5-qa-with-magnasense-cfo-christel-dahlberg/https://magnasense-dev.mywoosh.site/updates/5-qa-with-Magnasense-coo-vasiliki-fragkou/https://magnasense-dev.mywoosh.site/playground/https://magnasense-dev.mywoosh.site/playground1/inside-page/https://magnasense-dev.mywoosh.site/playground1/typo/https://magnasense-dev.mywoosh.site/playground1/greyheader/https://magnasense-dev.mywoosh.site/playground1/newsheader/https://magnasense-dev.mywoosh.site/team/dr-vasiliki-fragkou/https://magnasense-dev.mywoosh.site/team/william-vickery/https://magnasense-dev.mywoosh.site/team/fredrik-haglund/https://magnasense-dev.mywoosh.site/team/iain-l-c-chapple/https://magnasense-dev.mywoosh.site/team/adam-s-cheifetz-md/https://magnasense-dev.mywoosh.site/playground1/irnewsheader/https://magnasense-dev.mywoosh.site/conferences/https://magnasense-dev.mywoosh.site/conferences/ectrims-2022/https://magnasense-dev.mywoosh.site/conferences/actrims-2023/https://magnasense-dev.mywoosh.site/team/jens-umehag/https://magnasense-dev.mywoosh.site/team/marco-witteveen/https://magnasense-dev.mywoosh.site/team/michael-schwartz/https://magnasense-dev.mywoosh.site/team/william-ferenczy/https://magnasense-dev.mywoosh.site/playground/news/https://magnasense-dev.mywoosh.site/playground/headers/https://magnasense-dev.mywoosh.site/investor-relations/presentations/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-has-received-payment-of-tranche-2-of-sek-500-million-from-atlas-special-opportunities-llc/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-har-erhallit-utbetalning-av-tranche-2-om-5-00-msek-fran-atlas-special-opportunities-llc/https://magnasense-dev.mywoosh.site/team/associate-professor-melissa-grant/https://magnasense-dev.mywoosh.site/news/kommunike-fran-arsstamma-i-aegirbio-ab-publ-den-28-juni-2024/https://magnasense-dev.mywoosh.site/news/aegirbio-avser-genomfora-riktad-emission-till-atlas-special-opportunities-med-anledning-av-pakallade-konverteringar-om-totalt-2-50-msek/https://magnasense-dev.mywoosh.site/news/melissa-grant-joins-aegirbio-scientific-advisory-board/https://magnasense-dev.mywoosh.site/news/melissa-grant-ny-medlem-i-aegirbios-vetenskapliga-rad/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-byter-namn-till-magnasense-ab/https://magnasense-dev.mywoosh.site/news/aegirbio-ab-changes-name-to-magnasense-ab/https://magnasense-dev.mywoosh.site/news/magnasense-ab-carries-out-previously-announced-directed-share-issue-of-6-115-662-shares-to-atlas-special-opportunities-following-called-upon-conversions-of-sek-250-million/https://magnasense-dev.mywoosh.site/news/magnasense-ab-genomfor-tidigare-aviserad-riktad-nyemission-om-6-115-662-aktier-till-atlas-special-opportunities-med-anledning-av-pakallade-konverteringar-om-totalt-2-50-msek/https://magnasense-dev.mywoosh.site/news/magnasense-ab-pakallar-utbetalning-av-del-av-tranc/https://magnasense-dev.mywoosh.site/news/magnasense-ab-calls-for-partial-payment-of-tranche-3-of-sek-250-million-from-atlas-special-opportunities-llc/https://magnasense-dev.mywoosh.site/cookie-policy/https://magnasense-dev.mywoosh.site/privacy-policy/https://magnasense-dev.mywoosh.site/news/magnasense-utser-vicki-johnson-till-tillforordnad-/https://magnasense-dev.mywoosh.site/news/magnasense-appoints-vicki-johnson-as-interim-cfo/https://magnasense-dev.mywoosh.site/team/vicki-johnson/https://magnasense-dev.mywoosh.site/news/aegirbio-avger-delarsrapport-och-redogor-for-vasentliga-handelser-202405/https://magnasense-dev.mywoosh.site/updates/5-qa-with-magnasense-chairman-of-board-jens-umehag/https://magnasense-dev.mywoosh.site/updates/intervju-med-magnasenses-ordforande-jens-umehag-/https://magnasense-dev.mywoosh.site/news/magnasense-delarsrapport-april-juni-2024/https://magnasense-dev.mywoosh.site/news/magnasense-interim-report-april-june-2024/https://magnasense-dev.mywoosh.site/news/magnasense-ab-extends-the-payment-period-for-business-critical-supplier-invoices-totalling-usd-970-000-and-decides-on-a-directed-issue/https://magnasense-dev.mywoosh.site/news/magnasense-ab-forlanger-betalningsfristen-for-affa/https://magnasense-dev.mywoosh.site/news/magnasense-and-salignostics-initiate-feasibility-study-project/https://magnasense-dev.mywoosh.site/news/magnasense-och-salignostics-inleder-forstudieproje/https://magnasense-dev.mywoosh.site/news/magnasense-foljer-planen-i-radx-projektet/https://magnasense-dev.mywoosh.site/news/magnasense-on-track-in-radx-project/https://magnasense-dev.mywoosh.site/news/magnasense-lamnar-in-patentansokan/https://magnasense-dev.mywoosh.site/news/magnasense-files-a-patent-application/https://magnasense-dev.mywoosh.site/news/magnasense-intends-to-carry-out-a-directed-issue-t/https://magnasense-dev.mywoosh.site/news/magnasense-avser-genomfora-riktad-emission-till-at/https://magnasense-dev.mywoosh.site/news/magnasense-ab-genomfor-tidigare-aviserad-riktad-ny/https://magnasense-dev.mywoosh.site/news/magnasense-ab-carries-out-previously-announced-directed-share-issue-of-7-080-627-shares-to-atlas-special-opportunities-following-called-upon-conversions-of-sek-250-million/https://magnasense-dev.mywoosh.site/updates/5-qa-with-professor-iain-l-c-chapple/https://magnasense-dev.mywoosh.site/news/magnasense-ab-pakallar-utbetalning-av-del-av-tranc-2024-09-20/https://magnasense-dev.mywoosh.site/news/magnasense-ab-calls-for-partial-payment-of-tranche-3-of-sek-250-million-from-atlas-special-opportunities-llc/https://magnasense-dev.mywoosh.site/news/magnasense-upptar-lan-om-totalt-3-msek-fran-styrel/https://magnasense-dev.mywoosh.site/news/magnasense-obtain-loans-of-totaling-msek-3-from-board-members/https://magnasense-dev.mywoosh.site/updates/5-qas-with-michael-schwartz-magnasense-board-member/https://magnasense-dev.mywoosh.site/news/magnasense-avser-genomfora-riktad-emission-till-at-2024-10-31/https://magnasense-dev.mywoosh.site/news/magnasense-intends-to-carry-out-a-directed-issue-t-2024-10-31/https://magnasense-dev.mywoosh.site/news/magnasense-ab-carries-out-previously-announced-directed-share-issue-of-13-090-908-shares-to-atlas-special-opportunities-following-called-upon-conversions-of-sek-300-million/https://magnasense-dev.mywoosh.site/news/magnasense-ab-genomfor-tidigare-aviserad-riktad-nyemission-om-13-090-908-aktier-till-atlas-special-opportunities-med-anledning-av-pakallade-konverteringar-om-totalt-3-00-msek/https://magnasense-dev.mywoosh.site/news/magnasense-interim-report-july-september-2024/https://magnasense-dev.mywoosh.site/news/magnasense-delarsrapport-juli-september-2024/https://magnasense-dev.mywoosh.site/news/magnasense-ab-completes-radx-tech-project-under-ni/https://magnasense-dev.mywoosh.site/news/magnasense-avser-att-genomfora-en-foretradesemissi/https://magnasense-dev.mywoosh.site/news/magnasense-intends-to-carry-out-a-rights-issue-of-units-of-approx-sek-26m-to-develop-saliva-based-diagnostics-as-an-alternative-to-blood-testing-and-bring-forward-the-publication-of-the-q4-2024-report/https://magnasense-dev.mywoosh.site/news/kallelse-till-extra-bolagsstamma-i-magnasense-ab-p/https://magnasense-dev.mywoosh.site/news/magnasense-ab-announces-termination-of-agreement-w/https://magnasense-dev.mywoosh.site/news/magnasense-ab-ceo-marco-witteveen-provides-an-upda/https://magnasense-dev.mywoosh.site/news/magnasense-intends-to-carry-out-a-directed-issue-to-atlas-special-opportunities-due-to-called-on-conversions-totalling-sek-250-million/https://magnasense-dev.mywoosh.site/news/magnasense-avser-genomfora-riktad-emission-till-at-2025-02-17/https://magnasense-dev.mywoosh.site/news/magnasense-ab-genomfor-tidigare-aviserad-riktad-ny-2025-02-19/https://magnasense-dev.mywoosh.site/news/magnasense-ab-carries-out-previously-announced-directed-share-issue-of-22-420-632-shares-to-atlas-special-opportunities-following-called-upon-conversions-of-sek-250-million/https://magnasense-dev.mywoosh.site/news/regulatoriskt-pressmeddelande/https://magnasense-dev.mywoosh.site/news/magnasense-ab-aviserar-om-forandrad-tidplan-for-av/https://magnasense-dev.mywoosh.site/news/magnasense-technologies-oy-and-salofa-oy-reach-set/https://magnasense-dev.mywoosh.site/news/magnasense-interim-report-october-december-2024/https://magnasense-dev.mywoosh.site/news/magnasense-ab-ingar-tillaggsavtal-med-atlas-specia/https://magnasense-dev.mywoosh.site/news/magnasense-ab-enters-into-an-addendum-with-atlas-s/https://magnasense-dev.mywoosh.site/news/magnasense-beslutar-om-tidigare-aviserad-foretrade/https://magnasense-dev.mywoosh.site/news/magnasense-resolves-on-the-previously-announced-rights-issue-of-units-of-a-minimum-of-approx-msek-15-and-a-maximum-of-approx-msek-267-to-develop-saliva-based-diagnostics-as-an-alternative-to-blood-testing/